At a glance
- Originator Merck & Co
- Class Antivirals; Indans; Piperazines
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 12 Oct 2000 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 09 Jun 2000 New profile
- 09 Jun 1999 Preclinical development for HIV infections treatment in USA (Unknown route)